Important notification
31.01.2022 To the attention of interested persons An EU4Health Joint Action for the rapid assessment of multinational COVID-19 trials will […]
Press release
28.01.2022 To the attention of interested persons Start of a review concerning the conduct of studies at Synchron Research Services, […]
Press release
27.01.2022 To the attention of interested persons COVID-19: EMA recommends conditional marketing authorisation for Paxlovid download document …
Press release
14.01.2022 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 – 13 January […]
Important notification
17.01.2022 To the attention of all stakeholders (importers, distributors, users) The NAMMDR warns all stakeholders not to introduce on the […]
Press release
11.01.2022 To the attention of interested persons Preliminary data indicate COVID-19 vaccines remain effective against severe disease and hospitalisation caused […]
Press release
10.01.2022 To the attention of interested persons EMA receives application for conditional marketing authorisation for Paxlovid (PF-07321332 and ritonavir) for […]
Important notification
30.12.2021 To the attention of all wholesale distributors of medicinal products, authorised in Romania According to Minister of Health no. […]
Important notification
23.12.2021 To the attention of all users/distributors of PRP Blood Collection Tubes (Platelet Rich Plasma) / manufacturer ANHUI SINIC LABORATORY […]
Press release
17.12.2021 To the attention of interested persons Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 […]